It is the most investigated member of the Plk family, it plays a central role in the cell cycle 11 and it is overexpressed and associated with a poor prognosis in many cancers including HNSCC 6, 7, melanoma 28, and colon cancer 29 . Here, PLK1 is linked to melanoma.